within Pharmacolibrary.Drugs.ATC.C;

model C04AB02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0001,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C04AB02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tolazoline is a non-selective alpha-adrenergic antagonist that has been used as a vasodilator for the treatment of peripheral vascular diseases and in the management of pulmonary hypertension in newborns. However, its clinical use has largely been replaced by other agents, and it is not commonly used or approved in many current therapeutic guidelines.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adults based on available secondary data and class similarities, since direct published PK studies in humans are lacking.</p><h4>References</h4><ol><li><p>Casbeer, HC, &amp; Knych, HK (2013). Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses. <i>Veterinary journal (London, England : 1997)</i> 196(3) 504–509. DOI:<a href=\"https://doi.org/10.1016/j.tvjl.2012.12.006\">10.1016/j.tvjl.2012.12.006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23321455/\">https://pubmed.ncbi.nlm.nih.gov/23321455</a></p></li><li><p>Paret, G, et al., &amp; Ezra, D (1999). Pharmacokinetics of endobronchial tolazoline administration in dogs. <i>American journal of perinatology</i> 16(1) 1–6. DOI:<a href=\"https://doi.org/10.1055/s-2007-993827\">10.1055/s-2007-993827</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10362074/\">https://pubmed.ncbi.nlm.nih.gov/10362074</a></p></li><li><p>Conner, CS, &amp; Watanabe, AS (1979). Clonidine overdose: a review. <i>American journal of hospital pharmacy</i> 36(7) 906–911. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/382842/\">https://pubmed.ncbi.nlm.nih.gov/382842</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C04AB02;
